Newsletter

Excellentia Advisory Group

Complimentary Webinar & Archive Links

Excellentia Advisory Group would like to give back to our valued clients. We will be Providing Infection Prevention Education through on-going industry collaboration & sponsorships. Excellentia is proud to present one in a series of monthly complimentary educational webinars presented by vendors in the field of Infection Prevention for the ambulatory surgery center industry.

February’s webinar:

“The New Clostridium difficile: Pathogenicity, Complications, Prevention"

 

Presented by: Wava Truscott, PhD, MBA

Kimberly-Clark Healthcare, Director of Medical Science & Education

Presented: February 15, 2012


Cost: Complimentary

Upon viewing this webinar, fill out your Certificate Request Form and email to:

events@excellentiagroup.com

Click for Contact Hour Certificate Request Form (Excel .xls format)

Click for Contact Hour Certificate Request Form (Excel .xlsx format)

 

CLICK HERE TO REGISTER AND SEE WEBINAR

Sponsored By:

Wava Truscott, PhD., is Director of Medical Sciences & Clinical Education for Kimberly-Clark Health Care. Her doctorate is in Comparative Pathology emphasizing Microbiology, Immunology, and Pathology from the University of California. Her MBA is from the University of La Verne and her BS from Brigham Young University (BYU). Earlier in her career, Wava evaluated the safety and efficacy of medical devices at MIDECO Independent Laboratories, Managed the Biological Laboratories for the Pharmaseal Division of Baxter Healthcare, and was Vice President of Scientific Affairs for the SafeSkin Corporation. She spent years researching latex allergy from profiling the allergens derived from tapping the plantation trees, processing the latex and producing the gloves to developing ways to remove the offending proteins.

Dr. Truscott has authored over 70 articles, co-authored the Microbiological section of the AAMI Sterilization Recommended Practices, and served as the U.S. delegate to the International Standards Organization on Biocompatibility Testing of Medical Devices regarding Systemic Toxicity (ISO 10993-11) as the European Union was forming. She recently authored an extensive petition to the FDA requesting a ban on all powdered gloves used in healthcare and is currently the ASTM Chairman of the committee charged with developing test methods for medical gloves incorporated with antimicrobial agents.

About This Webinar:

Clostridium difficile infection is recognized as one of the most serious healthcare-associated infections occurring around the world today. Infections may be mild and resolve fairly rapidly after antibiotic cessation, or may be severe, lingering, recurring and life-threatening. Emergence of new strains with increased virulence, sporulation frequency and antibiotic resistance along with increased patient vulnerabilities, altered healthcare practices and new reservoirs are all contributing to the aggressive success of this not-so-glamorous superbug. The purpose of this educational program is to discuss the impact of Clostridium difficile, describe its new strains, recommend best practices for Ambulatory Surgery Centers and describe new technologies designed to prevent transmission.

Learner Objectives

Upon completion of this continuing education activity, the participant should be able to:

  1. * Identify conditions that make C. difficile a successful pathogen
  2. * List complications associated with infections (CDI)
  3. * Discuss reservoirs for nosocomial transmission
  4. * Describe best practices for transmission prevention

 

You will receive one-hour of continuing education credit* for attending this webinar. Excellentia Advisory Group will forward a Certificate of Participation for each licensed person that attends this webinar. You simply email the names and license numbers of each person on the CERTIFICATE REQUEST FORM or individually to events@excellentiagroup.com

Click for Contact Hour Certificate Request Form ( Excel .xls format)

Click for Contact Hour Certificate Request Form (Excel .xlsx format)


CLICK HERE TO REGISTER AND SEE ON-DEMAND WEBINAR

*To learn more about Kimberly-Clark Infection Prevention products, go to http://www.kimberly-clark.com/brands/kc_professional.aspx

*Excellentia Advisory Group is approved by the California Board of Registered Nursing.
• Provider CEP 15481
• Issue Date: 4/6/2010

Archived Webinar Links

December 2011- “What Do You Mean I Caused That Surgical Complication?” Presented by: Wava Truscott, PhD, Kimberly-Clark Healthcare

January 2012 - "Biofilms in Medicine:Implications for Ambulatory Surgical Centers" Presented by: Wava Truscott, PhD, Kimberly-Clark Healthcare

February 2012 - "The New Clostridium difficile: Pathogenicty, Complications, Prevention" Presented by: Wava Truscott, PhD, Kimberly-Clark Healthcare

March 2012 -"Check the Label: Is the Mask a Level 1, 2, or 3 (and...what's the difference?)" Presented by: Kathleen Stoessel, RN, BSN, MS, Kimberly-Clark Healthcare  

April 2012 - Partial- "What Every Ambulatory Surgery Center Professional Should Know About Steam Sterilization Monitoring" Presented by: Dorothy Larson, 3M Infection Prevention Division  

June 2012 - "Patient Complications Caused by Sterile Lint and Powder" Presented by: Wava Truscott, PhD, Kimberly-Clark Healthcare

 


Click for Contact Hour Certificate Request Form ( Excel .xls format)

Click for Contact Hour Certificate Request Form (Excel .xlsx format)